During the past decade, Iida Municipal Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Iida Municipal Hospital" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Iida Municipal Hospital" are "Colorectal Cancer" (2 trials), "Intra-abdominal Infections" (1 trials), "Macular Degeneration" (1 trials), "Neovascular Age-related Macular Degeneration" (1 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "Iida Municipal Hospital" in a lesser frequency.

Most popular intervention types in "Iida Municipal Hospital" are "Drug" (6 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (3 trials), "Faricimab" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "Abicipar Pegol" (1 trials) and "Aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Iida Municipal Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Iida Municipal Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Iida Municipal Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Iida Municipal Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".